Brain 17 Vienna

First page Table of contents Previous page 2276-2277 Next page Last page

Alectinib vs Crizotinib trial

survival

Brain metastases in patients with ALK-positive NSCLC

Peters et al 2017, N Engl J Med; 377: 829-38

Made with FlippingBook - Online catalogs